Q4 Earnings Forecast for Cresco Labs Issued By Roth Capital

Cresco Labs Inc. (OTCMKTS:CRLBFFree Report) – Research analysts at Roth Capital issued their Q4 2024 earnings per share (EPS) estimates for shares of Cresco Labs in a report released on Sunday, November 10th. Roth Capital analyst W. Kirk forecasts that the company will post earnings per share of ($0.01) for the quarter. Roth Capital currently has a “Strong-Buy” rating on the stock. The consensus estimate for Cresco Labs’ current full-year earnings is ($0.19) per share. Roth Capital also issued estimates for Cresco Labs’ Q1 2025 earnings at ($0.01) EPS, Q2 2025 earnings at $0.00 EPS, Q3 2025 earnings at $0.00 EPS, Q4 2025 earnings at $0.00 EPS and FY2025 earnings at ($0.01) EPS.

Other research analysts have also issued research reports about the stock. Needham & Company LLC reiterated a “hold” rating on shares of Cresco Labs in a research note on Monday, August 12th. Ventum Cap Mkts raised shares of Cresco Labs to a “strong-buy” rating in a report on Friday, August 9th. Two equities research analysts have rated the stock with a hold rating, two have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, Cresco Labs has a consensus rating of “Buy” and an average price target of $2.50.

View Our Latest Stock Report on Cresco Labs

Cresco Labs Stock Performance

Shares of Cresco Labs stock opened at $1.44 on Wednesday. The company has a market capitalization of $702.92 million, a PE ratio of -7.10 and a beta of 1.88. The company has a 50-day simple moving average of $1.58 and a two-hundred day simple moving average of $1.71. Cresco Labs has a one year low of $1.02 and a one year high of $2.65. The company has a debt-to-equity ratio of 1.76, a quick ratio of 1.30 and a current ratio of 2.00.

Cresco Labs Company Profile

(Get Free Report)

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.

Featured Articles

Earnings History and Estimates for Cresco Labs (OTCMKTS:CRLBF)

Receive News & Ratings for Cresco Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cresco Labs and related companies with MarketBeat.com's FREE daily email newsletter.